Sofwave Announces FDA Clearance of New Lifting Indications
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
The neurotoxin is characterized by a rapid onset of action as early as eight hours after administration and a shorter duration of effect of two to three weeks.